These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23245688)

  • 1. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
    Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta.
    Li X; Tan X; Yu Y; Chen H; Chang W; Hou J; Xu D; Ma L; Cao G
    Cancer; 2011 Sep; 117(18):4201-11. PubMed ID: 21387281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MHC class I expression and lymph node metastasis of gastric carcinoma.
    Yoshii M; Tanaka H; Ohira M; Muguruma K; Sakurai K; Kubo N; Yashiro M; Sawada T; Hirakawa K
    Hepatogastroenterology; 2013 May; 60(123):611-5. PubMed ID: 23108078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.
    Cai MY; Luo RZ; Li YH; Dong P; Zhang ZL; Zhou FJ; Chen JW; Yun JP; Zhang CZ; Cao Y
    Biochem Biophys Res Commun; 2012 Oct; 426(4):636-42. PubMed ID: 22982674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.
    Kroeger N; Seligson DB; Signoretti S; Yu H; Magyar CE; Huang J; Belldegrun AS; Pantuck AJ
    Eur J Cancer; 2014 May; 50(8):1531-40. PubMed ID: 24565854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
    Yoo SH; Lee K; Chae JY; Moon KC
    Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK
    Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
    Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
    BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
    Choi JW; Lee JH; Park HS; Kim YS
    J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
    Yang J; Cheng TT; Wang LN; Chen W; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma.
    Kitamura H; Honma I; Torigoe T; Asanuma H; Sato N; Tsukamoto T
    J Urol; 2007 Apr; 177(4):1269-72; discussion 1272. PubMed ID: 17382705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
    Lu X; Wan F; Zhang H; Shi G; Ye D
    Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.